Gland Pharma Income Statement
Quarterly
Yearly
The current prices are delayed, login to your account to see live prices.
LOGIN
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| EBITDA | 1,437 | 1,734 | 0 |
| EBIT | 1,338 | 1,624 | 0 |
| Earning Per Share | 62 | 73 | 47 |
| Expenses | 2,161 | 2,891 | 2,600 |
| Net Profit | 997 | 1,212 | 781 |
| Net Profit Margin | 29 | 28 | 22 |
| Operating Profit Margin | 41 | 39 | 35 |
| Profit Before Tax | 1,335 | 1,619 | 1,055 |
| Dividends Per Share | 0 | 0 | 0 |
| Operation Revenue | 3,598 | 4,625 | 3,865 |
Peer Comparison (in ₹.Cr.)
| Company | Year | EBIT | EBITDA | Net Profit | Net Worth | Profit Before Tax |
|---|---|---|---|---|---|---|
| 2023 | 0 | 0 | 8,560.84 | NA | 9,408.43 | |
| 2023 | 0 | 0 | 2,835.49 | NA | 4,038.35 | |
| 2023 | 0 | 0 | 372.90 | NA | 385.50 | |
| 2023 | 0 | 0 | 103.87 | NA | 140.39 | |
| 2022 | 1,257.60 | 2,182.90 | 978.50 | 7,628.10 | 1,190 |
The current prices are delayed, login to your account to see live prices.
LOGIN
| 2020 | 2021 | 2023 | |
|---|---|---|---|
| Operating Activities | 701 | 605 | 364 |
| Investing Activities | -766 | -1,524 | 1,208 |
| Financing Activities | -7 | 1,238 | 15 |
| Others | 0 | 0 | 0 |
| Net Cash Flow | -72 | 319 | 1,587 |
Peer Comparison (in ₹.Cr.)
| Company | Year | Operating Activities | Investing Activities | Financing Activities | Net Cash Flow |
|---|---|---|---|---|---|
| 2023 | 4,959.33 | -7,943.68 | 2,376.07 | -608.28 | |
| 2022 | 3,325.90 | -1,871.88 | -1,599.79 | -145.77 | |
| 2023 | 723.95 | -447.59 | -261.96 | 14.40 | |
| 2020 | 140.90 | -44.50 | -38.55 | 57.85 | |
| 2017 | 640 | -498.50 | -177.50 | -36 |
Financials
All values are in Rs Cr